Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-10-29
1982-01-19
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
128659, 260112B, 422 61, 424 15, 424 9, A61K 4900, A61K 4300, B65D 7100, G01T 100
Patent
active
043116884
ABSTRACT:
Antibody to anti human chorionic gonadotropin and/or antibody to anti human chorionic gonadotropin-beta subunit labeled with technetium-99m, iodine-123, iodine-125 or iodine-131 are/is administered to a human after the human has been administered anti-hCG and/or anti-hCG beta. The biodistribution of the labeled composition accumulates at cancer sites, e.g. tumors that produce human chorionic gonadotropin (hCG), human chorionic gonadotripin-like material, and a compound similar to and/or identical to the beta-chain of chorionic gonadotropin, or mixtures thereof which would bind specifically to anti-hCG and/or anti-hCG-beta.
REFERENCES:
patent: 4116776 (1978-09-01), Dalbow et al.
Burchiel Scott W.
Crockford David R.
Rhodes Buck A.
Cook Paul J.
Nucker Christine M.
Serono Laboratories Inc.
University Patents Inc.
LandOfFree
Composition and method for cancer detection in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for cancer detection in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for cancer detection in humans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1915035